Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gorman Cardiovascular Research is a medical technology company and research organization focused on developing innovative surgical devices and techniques for treating structural heart disease. Founded by Drs. Robert and Joseph Gorman, the entity specializes in image-guided mitral and tricuspid valve repair and therapies to mitigate post-infarction cardiac remodeling. Their work bridges the gap between academic research at the University of Pennsylvania and commercial medical device development, resulting in numerous patents for annuloplasty rings and percutaneous repair systems. The company's primary goal is to provide less invasive, more effective solutions for patients with complex cardiovascular conditions. Their technologies have been licensed to major medical device manufacturers and are utilized in clinical settings to improve surgical precision.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gorman Cardiovascular Research.